New sepsis therapy developed at VUMC edges closer to the clinic

According to research recently published in Frontiers in Immunology by Jacek Hawiger, MD, PhD (Allergy, Pulmonary and Critical Care Medicine), and colleagues, a “peptide genomic therapy” given in combination with an antibiotic nearly doubles survival rates from sepsis in an animal model, compared to treatment with antibiotic alone.